Search - tctmd.com

Displaying 201 - 220 of 265

Sort: Relevancy | Date

News Daily News

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Todd Neale

April 10, 2019

News Daily News

Baseline Anemia Ups Physician-Guided DAPT Discontinuation Rates After PCI

Yael L. Maxwell

April 10, 2019

News Daily News

Digital Tools Show Promise for Helping STEMI and NSTEMI Patients Avoid Readmission

L.A. McKeown

April 09, 2019

News Daily News

Organ Failure in Patients With Acute MI and Shock Is Prevalent and Rising

Michael O'Riordan

April 08, 2019

News Daily News

FDA Grants Approval to TherOx for Supersaturated Oxygen Therapy in LAD STEMI

L.A. McKeown

April 04, 2019

News Daily News

Volume Still an Important Surrogate for TAVR Quality, New Data Suggest

Todd Neale

April 03, 2019

News Daily News

AHA Statement on MINOCA Provides a Standard Definition, Clinical Care Algorithms

Yael L. Maxwell

April 03, 2019

News Daily News

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Michael O'Riordan

April 02, 2019

News Conference News ACC 2019

Myocardial Injury Often Miscoded as Type 2 MI

L.A. McKeown

April 02, 2019

News Daily News

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

L.A. McKeown

March 28, 2019

Presentation CIT 2019

No-Reflow in CHIP: Risk evaluation, Prevention, and Treatment

Presenter: Li Yue

March 28, 2019

Presentation CIT 2019

The CHIP Manifesto:Case Examples

Presenter: Ajay J. Kirtane

March 28, 2019

News Conference News ACC 2019

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Yael L. Maxwell

March 27, 2019

News Conference News ACC 2019

Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI

L.A. McKeown

March 27, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

Presentation SIF 2019

Salvaging a Disaster

Presenter: Katherine Harrington

March 27, 2019

Time and Money: PCI Public Reporting Requirements Takes Their Toll

News Conference News ACC 2019

Time and Money: PCI Public Reporting Requirements Take Their Toll

Michael O'Riordan

March 26, 2019

News Conference News ACC 2019

First Ticagrelor Reversal Agent Shows Quick Onset, Long Duration in Early Results

Yael L. Maxwell

March 25, 2019

News Conference News ACC 2019

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

Michael O'Riordan

March 21, 2019

News Conference News ACC 2019

No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel

Shelley Wood

March 19, 2019

Advertisement

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Baseline Anemia Ups Physician-Guided DAPT Discontinuation Rates After PCI

Digital Tools Show Promise for Helping STEMI and NSTEMI Patients Avoid Readmission

Organ Failure in Patients With Acute MI and Shock Is Prevalent and Rising

FDA Grants Approval to TherOx for Supersaturated Oxygen Therapy in LAD STEMI

Volume Still an Important Surrogate for TAVR Quality, New Data Suggest

AHA Statement on MINOCA Provides a Standard Definition, Clinical Care Algorithms

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Myocardial Injury Often Miscoded as Type 2 MI

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

No-Reflow in CHIP: Risk evaluation, Prevention, and Treatment

The CHIP Manifesto:Case Examples

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Salvaging a Disaster

Time and Money: PCI Public Reporting Requirements Take Their Toll

First Ticagrelor Reversal Agent Shows Quick Onset, Long Duration in Early Results

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content